27-Aug-2026
Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Tue, 25-Aug 10:18 AM ET)
PRNewswire (Fri, 21-Aug 10:00 PM ET)
PRNewswire (Fri, 31-Jul 10:00 AM ET)
Globe Newswire (Tue, 28-Jul 4:51 PM ET)
Business Wire (Tue, 28-Jul 4:05 PM ET)
Business Wire (Mon, 27-Jul 3:50 PM ET)
Acadia Healthcare Announces Date for Second Quarter 2026 Earnings Release
Business Wire (Thu, 9-Jul 4:15 PM ET)
Market Chameleon (Wed, 25-Feb 6:14 AM ET)
Volume Growth Drives Acadia's Record Revenue in Q4 2025 as Leadership Shifts with New CEO
Market Chameleon (Wed, 25-Feb 2:54 AM ET)
Acadia Healthcare Reaffirms 2025 Outlook as Debbie Osteen Returns to Lead Company
Market Chameleon (Tue, 20-Jan 3:54 AM ET)
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.
Acadia Healthcare Company trades on the NASDAQ stock market under the symbol ACHC.
As of August 27, 2026, ACHC stock price declined to $30.22 with 1,240,601 million shares trading.
ACHC has a beta of 0.30, meaning it tends to be less sensitive to market movements. ACHC has a correlation of 0.00 to the broad based SPY ETF.
ACHC has a market cap of $2.81 billion. This is considered a Mid Cap stock.
Last quarter Acadia Healthcare Company reported $866 million in Revenue and $.38 earnings per share. This beat revenue expectation by $20 million and exceeded earnings estimates by $.02.
In the last 3 years, ACHC traded as high as $87.77 and as low as $11.43.
The top ETF exchange traded funds that ACHC belongs to (by Net Assets): IJR, VTI, AVUV, IWM, VB.
ACHC has outperformed the market in the last year with a return of +40.2%, while the SPY ETF gained +20.7%. In the last 3 month period, ACHC beat the market returning +28.7%, while SPY returned +3.0%. However, in the most recent 2 weeks ACHC has underperformed the stock market by returning -4.7%, while SPY returned -0.2%.
ACHC support price is $29.37 and resistance is $31.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACHC shares will trade within this expected range on the day.
